| 102.95 BATS BZX Real-Time Price As of 3:47pm ET |  -0.20 / -0.19%Today’s Change | 78.95 Today|||52-Week Range 111.54 | +23.63% Year-to-Date |
| Why Is Quest Diagnostics (DGX) Down 0.2% Since Last Earnings Report? 9:30am / Zacks.com - Paid Partner Content | Outlook for Outpatient and Home Healthcare Industry Looks Bright Aug 16 / Zacks.com - Paid Partner Content |
| Should Value Investors Pick Quest Diagnostics (DGX) Stock? Aug 20 / Zacks.com - Paid Partner Content |
| Previous close | 103.15 |
| Today’s open | 103.30 |
| Day’s range | 102.05 - 103.60 |
| Volume | 676,902 |
| Average volume (3 months) | 1,011,228 |
| Market cap | $13.5B |
| Earnings growth (last year) | -3.97% |
| Earnings growth (this year) | +2.96% |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | -2.31% |
| P/E ratio | 20.0 |
| Price/Sales | 1.54 |
| Price/Book | 2.60 |
| Today’s change | Today’s % change | |
|---|---|---|
| LHLaboratory Corporati... | -0.16 | -0.09% |
| GHGuardant Health Inc | -5.45 | -5.22% |
| GHDXGenomic Health Inc | -0.53 | -0.71% |
| NEONeogenomics Inc | -0.35 | -1.33% |
| Next reporting date | October 23, 2019 |
| EPS forecast (this quarter) | $1.71 |
| Annual revenue (last year) | $7.5B |
| Annual profit (last year) | $733.0M |
| Net profit margin | 9.73% |
Sector Health Services |
Industry Services to the Health Industry |
Chairman, President & Chief Executive Officer Stephen H. Rusckowski |
Chief Financial Officer & Executive Vice President Mark J. Guinan |
Corporate headquarters Secaucus, New Jersey |
